In the last trading session, 1.93 million shares of the Autolus Therapeutics plc ADR (NASDAQ:AUTL) were traded, and its beta was 1.69. Most recently the company’s share price was $1.18, and it changed around -$0.15 or -11.28% from the last close, which brings the market valuation of the company to $314.02M. AUTL currently trades at a discount to its 52-week high of $5.00, offering almost -323.73% off that amount. The share price’s 52-week low was $1.11, which indicates that the current value has risen by an impressive 5.93% since then.
Autolus Therapeutics plc ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 10 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended AUTL as a Hold, whereas 8 deemed it a Buy, and 0 rated it as Underweight.
Autolus Therapeutics plc ADR (NASDAQ:AUTL) trade information
Instantly AUTL has showed a red trend with a performance of -11.28% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.4400 on recent trading dayincreased the stock’s daily price by 18.06%. The company’s shares are currently down -49.79% year-to-date, but still down -9.92% over the last five days. On the other hand, Autolus Therapeutics plc ADR (NASDAQ:AUTL) is -11.28% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $7.6, which translates to bulls needing to increase their stock price by 84.47% from its current value. Analyst projections state that AUTL is forecast to be at a low of $7.6 and a high of $7.6.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 21.36%. Autolus Therapeutics plc ADR earnings are expected to increase by -4.89% in 2025, but the outlook is positive 22.51% per year for the next five years.
AUTL Dividends
Autolus Therapeutics plc ADR’s next quarterly earnings report is expected to be released in June.
BLACKSTONE INC., with 7.7006% or 20.49 million shares worth $71.29 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and Fidelity Securities Fund-Fidelity Small Cap Growth Fund were the top two Mutual Funds as of Jan 31, 2025 . The former held 19.36 shares worth $22.84 million, making up 7.27% of all outstanding shares. On the other hand, Fidelity Securities Fund-Fidelity Small Cap Growth Fund held roughly 2.57 shares worth around $3.03 million, which represents about 0.97% of the total shares outstanding.
